BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29649984)

  • 1. BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway.
    Ledet MM; Anderson R; Harman R; Muth A; Thompson PR; Coonrod SA; Van de Walle GR
    BMC Cancer; 2018 Apr; 18(1):412. PubMed ID: 29649984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species.
    Harman RM; Curtis TM; Argyle DJ; Coonrod SA; Van de Walle GR
    J Mammary Gland Biol Neoplasia; 2016 Jun; 21(1-2):51-66. PubMed ID: 27002722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells.
    Wang LS; Huang YW; Liu S; Chang HL; Ye W; Shu S; Sugimoto Y; Funk JA; Smeaks DD; Hill LN; Lin YC
    Anticancer Res; 2006; 26(2A):889-98. PubMed ID: 16619484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducement of ER Stress by PAD Inhibitor BB-Cl-Amidine to Effectively Kill AML Cells.
    Sun YN; Ma YN; Jia XQ; Yao Q; Chen JP; Li H
    Curr Med Sci; 2022 Oct; 42(5):958-965. PubMed ID: 36245030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
    Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
    Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of peptidylarginine deiminase-2 expression in canine, feline and human mammary tumours.
    Cherrington BD; Mohanan S; Diep AN; Fleiss R; Sudilovsky D; Anguish LJ; Coonrod SA; Wakshlag JJ
    J Comp Pathol; 2012; 147(2-3):139-46. PubMed ID: 22520816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Characterization of the Lactating Mouse Mammary Gland Citrullinome.
    Li G; Young CH; Snow B; Christensen AO; Demoruelle MK; Nemmara VV; Thompson PR; Rothfuss HM; Cherrington BD
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis.
    Zhang B; Han H; Fu S; Yang P; Gu Z; Zhou Q; Cao Z
    Biochem Pharmacol; 2016 Mar; 104():8-18. PubMed ID: 26774454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor effect of bevacizumab on a xenograft model of feline mammary carcinoma.
    Michishita M; Ohtsuka A; Nakahira R; Tajima T; Nakagawa T; Sasaki N; Arai T; Takahashi K
    J Vet Med Sci; 2016 May; 78(4):685-9. PubMed ID: 26616000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The investigation of cytotoxic and apoptotic activity of Cl-amidine on the human U-87 MG glioma cell line.
    Öğüten PN; Engür Öztürk S; Dikmen M
    Medicine (Baltimore); 2024 Feb; 103(8):e37015. PubMed ID: 38394536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway.
    Han KS; Li N; Raven PA; Fazli L; Frees S; Ettinger S; Park KC; Hong SJ; Gleave ME; So AI
    Oncotarget; 2015 Oct; 6(33):34818-30. PubMed ID: 26472187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
    Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
    Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of tissue inhibitor of metalloproteinase 4 from complex canine mammary carcinomas.
    Kaur N; Sunil Kumar BV; Mahajan K; Singh S
    J Immunoassay Immunochem; 2016; 37(5):515-26. PubMed ID: 26979595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feline STK gene expression in mammary carcinomas.
    De Maria R; Maggiora P; Biolatti B; Prat M; Comoglio PM; Castagnaro M; Di Renzo MF
    Oncogene; 2002 Mar; 21(11):1785-90. PubMed ID: 11896610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
    Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
    BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.
    Ma B; Zhang H; Wang Y; Zhao A; Zhu Z; Bao X; Sun Y; Li L; Zhang Q
    J Exp Clin Cancer Res; 2018 Sep; 37(1):210. PubMed ID: 30176898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours.
    Penzo C; Ross M; Muirhead R; Else R; Argyle DJ
    Vet Comp Oncol; 2009 Dec; 7(4):222-9. PubMed ID: 19891692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
    Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
    J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
    McElwee JL; Mohanan S; Griffith OL; Breuer HC; Anguish LJ; Cherrington BD; Palmer AM; Howe LR; Subramanian V; Causey CP; Thompson PR; Gray JW; Coonrod SA
    BMC Cancer; 2012 Oct; 12():500. PubMed ID: 23110523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.